MIPS - Quality Measures - Achievement of Projected Effective Dose of Standardized Allergens for Patient Treated With Allergen Immunotherapy for at Least One Year
Proportion of patients receiving subcutaneous allergen immunotherapy that contains at least one standardized extract (mite, ragweed, grass, and/or cat) who achieved the projected effective dose for all included standardized allergen extract(s) after at least one year of treatment. National Quality Strategy Domain: Effective Clinical Care Outcome Measure
eMeasure ID
First Performance Year
2017
Last Performance Year
Metric Type
Single Performance Rate
National Quality Strategy Domain
Effective Clinical Care
Measure Type
Outcome
eMeasure UUID
NQF eMeasure ID
NQF ID
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward
AAAAI American Academy of Allergy, Asthma, and Immunology Quality Clinical Data Registry Powered by Premier, Inc.